YU13293A - Postupak za dobijanje antagonista fibrinogen receptora - Google Patents
Postupak za dobijanje antagonista fibrinogen receptoraInfo
- Publication number
- YU13293A YU13293A YU13293A YU13293A YU13293A YU 13293 A YU13293 A YU 13293A YU 13293 A YU13293 A YU 13293A YU 13293 A YU13293 A YU 13293A YU 13293 A YU13293 A YU 13293A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- procedure
- receptor antagonists
- heteroatoms
- fibrinogen receptor
- alkyl
- Prior art date
Links
- 239000002319 fibrinogen receptor antagonist Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 238000003786 synthesis reaction Methods 0.000 abstract 3
- FKNQCJSGGFJEIZ-UHFFFAOYSA-N 4-methylpyridine Chemical compound CC1=CC=NC=C1 FKNQCJSGGFJEIZ-UHFFFAOYSA-N 0.000 abstract 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 2
- 125000005842 heteroatom Chemical group 0.000 abstract 2
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 1
- 238000010934 O-alkylation reaction Methods 0.000 abstract 1
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium on carbon Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 239000006227 byproduct Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 238000005984 hydrogenation reaction Methods 0.000 abstract 1
- 239000000047 product Substances 0.000 abstract 1
- 238000001953 recrystallisation Methods 0.000 abstract 1
- 238000007127 saponification reaction Methods 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 150000003667 tyrosine derivatives Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84369092A | 1992-02-28 | 1992-02-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| YU13293A true YU13293A (sh) | 1997-07-31 |
Family
ID=25290743
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU13293A YU13293A (sh) | 1992-02-28 | 1993-02-25 | Postupak za dobijanje antagonista fibrinogen receptora |
Country Status (12)
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0925063A4 (en) * | 1996-07-01 | 2000-12-27 | Lilly Co Eli | Blood-glucose-lowering and lipid-lowering compounds |
| US6623981B2 (en) * | 1998-01-27 | 2003-09-23 | Bristol-Myers Squibb Company | Detection of patients at risk for developing integrin antagonist/agonist mediated disease states |
| GB9812088D0 (en) * | 1998-06-05 | 1998-08-05 | Celltech Therapeutics Ltd | Chemical compounds |
| US6358982B1 (en) * | 1998-07-31 | 2002-03-19 | Eli Lilly And Company | Heterocyclyl sulphonamide derivatives |
| US6518244B2 (en) | 2000-03-09 | 2003-02-11 | Intimax Corporation | Combinations of heparin cofactor II agonist and platelet IIb/IIIa antagonist, and uses thereof |
| CN102241622A (zh) * | 2010-05-13 | 2011-11-16 | 上海医药工业研究院 | 一种制备盐酸替罗非班的方法 |
| CN101870672B (zh) * | 2010-07-05 | 2011-08-24 | 武汉同源药业有限公司 | 一种化合物盐酸替罗非班的制备方法 |
| CN101898998B (zh) * | 2010-08-25 | 2012-09-19 | 武汉武药科技有限公司 | 一种盐酸替罗非班中间体的制备方法 |
| CN102875449B (zh) * | 2012-10-15 | 2014-08-06 | 天津南开允公医药科技有限公司 | 盐酸替罗非班异构体分离方法及d构型盐酸替罗非班定量方法 |
| CN103848775A (zh) * | 2012-11-29 | 2014-06-11 | 上海信谊药厂有限公司 | 制备盐酸替罗非班的方法 |
| CN109608387A (zh) * | 2019-01-02 | 2019-04-12 | 海门慧聚药业有限公司 | 盐酸替罗非班的制备 |
| CN111100066B (zh) * | 2019-11-29 | 2021-07-30 | 石药集团恩必普药业有限公司 | 一种盐酸替罗非班中间体及盐酸替罗非班的制备方法 |
| CN115181058B (zh) * | 2021-04-01 | 2024-06-11 | 武汉武药科技有限公司 | 组合物及其质量控制方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3412138A (en) * | 1965-12-17 | 1968-11-19 | Ibm | Alkylation of tyrosine |
| NZ239846A (en) * | 1990-09-27 | 1994-11-25 | Merck & Co Inc | Sulphonamide derivatives and pharmaceutical compositions thereof |
-
1993
- 1993-02-16 US US08/017,922 patent/US5312923A/en not_active Expired - Fee Related
- 1993-02-20 TW TW082101201A patent/TW232008B/zh active
- 1993-02-24 AU AU37313/93A patent/AU3731393A/en not_active Abandoned
- 1993-02-24 WO PCT/US1993/001621 patent/WO1993016994A1/en active IP Right Grant
- 1993-02-24 RO RO94-01434A patent/RO115724B1/ro unknown
- 1993-02-24 RU RU94041212/04A patent/RU2113432C1/ru not_active IP Right Cessation
- 1993-02-24 CZ CZ942056A patent/CZ282770B6/cs not_active IP Right Cessation
- 1993-02-24 SK SK1024-94A patent/SK280164B6/sk unknown
- 1993-02-24 HU HU9402462A patent/HU223578B1/hu not_active IP Right Cessation
- 1993-02-25 YU YU13293A patent/YU13293A/sh unknown
- 1993-02-27 CN CN93102134A patent/CN1040534C/zh not_active Expired - Fee Related
-
1994
- 1994-08-26 FI FI943934A patent/FI106024B/fi active
Also Published As
| Publication number | Publication date |
|---|---|
| FI943934A0 (fi) | 1994-08-26 |
| HUT70545A (en) | 1995-10-30 |
| RU94041212A (ru) | 1996-06-20 |
| US5312923A (en) | 1994-05-17 |
| HU223578B1 (hu) | 2004-09-28 |
| CN1076442A (zh) | 1993-09-22 |
| CN1040534C (zh) | 1998-11-04 |
| FI943934L (fi) | 1994-10-05 |
| FI106024B (fi) | 2000-11-15 |
| SK102494A3 (en) | 1995-04-12 |
| WO1993016994A1 (en) | 1993-09-02 |
| RO115724B1 (ro) | 2000-05-30 |
| TW232008B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1994-10-11 |
| AU3731393A (en) | 1993-09-13 |
| HU9402462D0 (en) | 1994-10-28 |
| SK280164B6 (sk) | 1999-09-10 |
| CZ205694A3 (en) | 1995-10-18 |
| RU2113432C1 (ru) | 1998-06-20 |
| CZ282770B6 (cs) | 1997-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU13293A (sh) | Postupak za dobijanje antagonista fibrinogen receptora | |
| MX155144A (es) | Procedimiento para preparar un derivado de acilo substituido de los acidos 1,2,3,4-tetrahidro isoquinolin-3-carboxilicos | |
| US20040224959A1 (en) | Nitrogen-containing heterocyclic compounds and benzamide compounds and drugs containing the same | |
| AU685772B2 (en) | HIV protease inhibitors useful for the treatment of AIDS | |
| BG49940A3 (bg) | Метод за получаване на производни на 4-/4-фенил-1-пиперазинил/- феноли | |
| YU8703A (sh) | Derivati 4-fenil-piridina kao antagonisti receptora neurokinina-1 | |
| DK167804B1 (da) | Pyridin-2,4- og -2,5-dicarboxylsyreamider og deres fremstilling | |
| DE60110896T2 (de) | Carboxamide und ihre verwendung als inhibitoren des mikrosomalen triglycerid-transfer-proteins und der apolipoprotein b (apo b) sekretion | |
| AU692509B2 (en) | HIV protease inhibitors | |
| YU13193A (sh) | Postupak za dobijanje antagonista fibrinogen receptora | |
| YU4795A (sh) | Derivati indola koji se mogu koristiti kao 5ht agonisti, farmaceutski preparati koji ih sadrže i postupci njihovog dobijanja | |
| YU48197B (sh) | Derivati 4-aminopiridina i postupak za dobijanje njihovih smeša | |
| JP2550369B2 (ja) | 二環式アミノカルボン酸誘導体 | |
| DK0902018T3 (da) | 2-(arylpheny)amino-imidazolinderivater | |
| HU190445B (en) | Process for producing salicylic acid-derivatives and pharmaceutical compositions containing the same | |
| US5143926A (en) | Substituted pyridine-2,4-dicarboxylic acid compounds and methods of use thereof | |
| YU62801A (sh) | Derivati 4-heterociklilsulfonamidil-6-metoksi-5-(2-metoksi- fenoksi)-2-piridil- piridimina, njihovo dobivanje i primena kao antagonisti endotelinskih receptora | |
| LT3798B (en) | Method for the preparation of n,n'-bis(alkoxyalkyl)-pyrimidine-2,4-dicarboxylic acids diamides and use thereof | |
| ES8707549A1 (es) | Un procedimiento para preparar compuestos peptidicos sustituidos | |
| DE2438851C2 (de) | N↑2↑-Dansyl-L-argininderivate, ihre Salze mit Säuren, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE3839401A1 (de) | N-heterocyclische alkohol-derivate | |
| DE3863214D1 (de) | Glutaminsaeurederivate, ihre salze, verfahren zu ihrer herstellung, verwendung als arzneimittel und diese enthaltende zusammensetzungen. | |
| AR002715A1 (es) | Derivados de piperazina y piperazinona heterociclos substituidos particularmente utiles como antagonistas de los receptores de taquikinina,composicion farmaceutica que incluye uno de dichos derivados, uso de dichos compuestos en la preparacion de las composiciones y procedimiento para la preparacion de los derivados | |
| Kaye | 2-Lepidyl substituted diamines | |
| Becher et al. | Pyridinethiones. IX preparation of ricinidine, thioricinidine and other 2 (1H)‐pyridones and‐thiones related to nicotinic acid |